Literature DB >> 24280216

Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate.

Mauro Federici1, Emanuele Claudio Latagliata, Ada Ledonne, Francesca R Rizzo, Marco Feligioni, Dave Sulzer, Matthew Dunn, Dalibor Sames, Howard Gu, Robert Nisticò, Stefano Puglisi-Allegra, Nicola B Mercuri.   

Abstract

We combined in vitro amperometric, optical analysis of fluorescent false neurotransmitters and microdialysis techniques to unveil that cocaine and methylphenidate induced a marked depression of the synaptic release of dopamine (DA) in mouse striatum. In contrast to the classical dopamine transporter (DAT)-dependent enhancement of the dopaminergic signal observed at concentrations of cocaine lower than 3 μM, the inhibitory effect of cocaine was found at concentrations higher than 3 μM. The paradoxical inhibitory effect of cocaine and methylphenidate was associated with a decrease in synapsin phosphorylation. Interestingly, a cocaine-induced depression of DA release was only present in cocaine-insensitive animals (DAT-CI). Similar effects of cocaine were produced by methylphenidate in both wild-type and DAT-CI mice. On the other hand, nomifensine only enhanced the dopaminergic signal either in wild-type or in DAT-CI mice. Overall, these results indicate that cocaine and methylphenidate can increase or decrease DA neurotransmission by blocking reuptake and reducing the exocytotic release, respectively. The biphasic reshaping of DA neurotransmission could contribute to different behavioral effects of psychostimulants, including the calming ones, in attention deficit hyperactivity disorder.

Entities:  

Keywords:  Amperometry; Cocaine; Dopamine; Dopamine Transporters; Drug Action; Electrophysiology; Microdialysis; Striatum; Transgenic Mice

Mesh:

Substances:

Year:  2013        PMID: 24280216      PMCID: PMC3879549          DOI: 10.1074/jbc.M113.495499

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Addiction, dopamine, and the molecular mechanisms of memory.

Authors:  J D Berke; S E Hyman
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

Review 2.  New concepts in cocaine addiction: the dopamine depletion hypothesis.

Authors:  C A Dackis; M S Gold
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

Review 3.  Cellular and molecular mechanisms of drug dependence.

Authors:  G F Koob; F E Bloom
Journal:  Science       Date:  1988-11-04       Impact factor: 47.728

4.  Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum.

Authors:  P Hunt; M Kannengiesser; J Raynaud
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

5.  Cocaine produces locomotor stimulation in SS but not LS mice: relationship to dopaminergic function.

Authors:  F R George; M C Ritz
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Partial purification and characterization of the vacuolar H(+)-ATPase of mammalian synaptic vesicles.

Authors:  E Floor; P S Leventhal; S F Schaeffer
Journal:  J Neurochem       Date:  1990-11       Impact factor: 5.372

7.  Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation.

Authors:  R Geracitano; E Paolucci; S Prisco; E Guatteo; C Zona; P Longone; M Ammassari-Teule; G Bernardi; N Berretta; N B Mercuri
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

8.  LC/MS/MS evaluation of cocaine and its metabolites in different brain areas, peripheral organs and plasma in cocaine self-administering rats.

Authors:  Beata Bystrowska; Przemysław Adamczyk; Andrzej Moniczewski; Magdalena Zaniewska; Kjell Fuxe; Małgorzata Filip
Journal:  Pharmacol Rep       Date:  2012       Impact factor: 3.024

9.  Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats.

Authors:  Jilla Sabeti; Greg A Gerhardt; Nancy R Zahniser
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

10.  Individual differences in cocaine-induced locomotor activity in rats: behavioral characteristics, cocaine pharmacokinetics, and the dopamine transporter.

Authors:  Joshua M Gulley; Brian R Hoover; Gaynor A Larson; Nancy R Zahniser
Journal:  Neuropsychopharmacology       Date:  2003-12       Impact factor: 7.853

View more
  10 in total

1.  Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine.

Authors:  Zachary D Brodnik; Emily M Black; Meagan J Clark; Kristen N Kornsey; Nathaniel W Snyder; Rodrigo A España
Journal:  Neuropharmacology       Date:  2017-08-01       Impact factor: 5.250

Review 2.  Synaptic optical imaging platforms: Examining pharmacological modulation of neurotransmitter release at discrete synapses.

Authors:  Paolomi Merchant; David Sulzer; Dalibor Sames
Journal:  Neuropharmacology       Date:  2015-03-30       Impact factor: 5.250

3.  Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.

Authors:  A Ledonne; A Nobili; E C Latagliata; V Cavallucci; E Guatteo; S Puglisi-Allegra; M D'Amelio; N B Mercuri
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

4.  Accelerated development of cocaine-associated dopamine transients and cocaine use vulnerability following traumatic stress.

Authors:  Zachary D Brodnik; Emily M Black; Rodrigo A España
Journal:  Neuropsychopharmacology       Date:  2019-09-20       Impact factor: 7.853

5.  Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.

Authors:  Joshua D Gross; Shane W Kaski; Adam B Schroer; Kimberley A Wix; David P Siderovski; Vincent Setola
Journal:  J Psychopharmacol       Date:  2018-01-24       Impact factor: 4.153

6.  Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum.

Authors:  Jordan T Yorgason; Erin S Calipari; Mark J Ferris; Anushree N Karkhanis; Steven C Fordahl; Jeffrey L Weiner; Sara R Jones
Journal:  Neuropharmacology       Date:  2015-10-23       Impact factor: 5.250

7.  Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine.

Authors:  David L Bernstein; Preeti S Badve; Jessica R Barson; Caroline E Bass; Rodrigo A España
Journal:  Addict Biol       Date:  2017-10-02       Impact factor: 4.280

8.  Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.

Authors:  Alessandro Tozzi; Michela Tantucci; Saverio Marchi; Petra Mazzocchetti; Michele Morari; Paolo Pinton; Andrea Mancini; Paolo Calabresi
Journal:  Cell Death Dis       Date:  2018-02-12       Impact factor: 8.469

9.  Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease.

Authors:  Paraskevi Krashia; Alberto Cordella; Annalisa Nobili; Valerio Chiurchiù; Marcello D'Amelio; Nicola Biagio Mercuri; Livia La Barbera; Mauro Federici; Alessandro Leuti; Federica Campanelli; Giuseppina Natale; Gioia Marino; Valeria Calabrese; Francescangelo Vedele; Veronica Ghiglieri; Barbara Picconi; Giulia Di Lazzaro; Tommaso Schirinzi; Giulia Sancesario; Nicolas Casadei; Olaf Riess; Sergio Bernardini; Antonio Pisani; Paolo Calabresi; Maria Teresa Viscomi; Charles Nicholas Serhan
Journal:  Nat Commun       Date:  2019-09-02       Impact factor: 14.919

10.  Striatal dopamine neurotransmission: regulation of release and uptake.

Authors:  David Sulzer; Stephanie J Cragg; Margaret E Rice
Journal:  Basal Ganglia       Date:  2016-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.